Cargando…

Curbside particulate matter and susceptibility to SARS–CoV-2 infection

BACKGROUND: Biologic plausibility for the association between exposure to particulate matter (PM) less than 10 μm in aerodynamic diameter (PM(10)) and coronavirus disease 2019 (COVID-19) morbidity in epidemiologic studies has not been determined. The upregulation of angiotensin-converting enzyme 2 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyashita, Lisa, Foley, Gary, Semple, Sean, Gibbons, Joseph M., Pade, Corinna, McKnight, Áine, Grigg, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509961/ https://www.ncbi.nlm.nih.gov/pubmed/37781647 http://dx.doi.org/10.1016/j.jacig.2023.100141

Ejemplares similares

Underground railway particulate matter and susceptibility to pneumococcal infection
por: Miyashita, Lisa, et al.
Publicado: (2022)

Exposure to Particulate Matter Increases Expression of the Angiotensin converting enzyme-2 (ACE2) Receptor
por: Miyashita, Lisa, et al.
Publicado: (2022)

Confocal microscopy 3D imaging of diesel particulate matter
por: Miyashita, Lisa, et al.
Publicado: (2021)

Curbside recycling at the synapse
por: Powell, Kendall
Publicado: (2005)

Curbside (Corridor to the E-corridor) Consultations and the Dermatologists
por: Ashique, Karalikkattil T.
Publicado: (2017)

Curbside COVID Care as an Interdisciplinary Approach for Obstetric Patients
por: Lee, Lori, et al.
Publicado: (2023)

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
por: Jolliffe, David A., et al.
Publicado: (2022)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

The presence of air pollution particulate matter in cryopreserved placental tissue cells
por: Liu, Norrice M., et al.
Publicado: (2021)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Managing the curb – Public space and use of curbside cafes during the Coronavirus pandemic
por: Mandhan, Sneha, et al.
Publicado: (2023)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Emergency Center Curbside Screening During the COVID-19 Pandemic: Retrospective Cohort Study
por: Halalau, Alexandra, et al.
Publicado: (2020)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

Bus queue time estimation model for a curbside bus stop considering the blocking effect
por: Luo, Tian, et al.
Publicado: (2022)

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
por: Doykov, Ivan, et al.
Publicado: (2022)

Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice
por: Zhu, Teng-Yu, et al.
Publicado: (2021)

Critical assessment of day time traffic noise level at curbside open-air microenvironment of Kolkata City, India
por: Kundu Chowdhury, Anirban, et al.
Publicado: (2015)

#Curbsiding: Potential Value and Patient Confidentiality Implications of Infectious Disease Clinician Peer Consultations via Social Media
por: Boyland, Ryan, et al.
Publicado: (2022)

Studying the effect of particulate matter as SARS-CoV-2 transmitters
por: Hakami, Abdulrahim R., et al.
Publicado: (2021)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Exposure assessment of particulate matter for susceptible populations in Seattle.
por: Liu, L-J Sally, et al.
Publicado: (2003)

Particulate Matter–Induced Health Effects: Who Is Susceptible?
por: Inoue, Ken-ichiro, et al.
Publicado: (2011)

Particulate Matter–Induced Health Effects: Who Is Susceptible?
por: Sacks, Jason D., et al.
Publicado: (2011)

1003. Curbsiding Twitter: Potential Value and Patient Confidentiality Implications of Infectious Diseases Clinician Peer Consultations via Social Media
por: Boyland, Ryan, et al.
Publicado: (2022)

A particulate matter: How environmental irritants and particulate matter increase sensitivity to bacterial respiratory tract infections. Commentary for “Underground railway particulate matter and susceptibility to pneumococcal infection”
por: Hakansson, Anders P.
Publicado: (2022)

Exposure to fine particulate matter (PM(2.5)) from non-tobacco sources in homes within high-income countries: a systematic review
por: Wei, Shuying, et al.
Publicado: (2022)

Carbonaceous particulate matter on the lung surface from adults living in São Paulo, Brazil
por: Padovan, Michele Galhardoni, et al.
Publicado: (2017)

Particulate matter and SARS-CoV-2: A possible model of COVID-19 transmission
por: Tung, Nguyen Thanh, et al.
Publicado: (2021)

The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation
por: Mescoli, Ada, et al.
Publicado: (2020)

SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
por: Setti, Leonardo, et al.
Publicado: (2020)

Particulate matter (PM(2.5)) as a potential SARS-CoV-2 carrier
por: Nor, Norefrina Shafinaz Md, et al.
Publicado: (2021)

A whole genome screen for HIV restriction factors
por: Liu, Li, et al.
Publicado: (2011)

The ins and outs of HIV restriction
por: McKnight, Áine
Publicado: (2013)

Personal exposures to fine particulate matter and carbon monoxide in relation to cooking activities in rural Malawi
por: Saleh, Sepeedeh, et al.
Publicado: (2023)

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Milojkovic, Dragana, et al.
Publicado: (2022)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r1hhfobn6uhjfo7d59svopsrak